A detailed history of Retirement Systems Of Alabama transactions in Abb Vie Inc. stock. As of the latest transaction made, Retirement Systems Of Alabama holds 901,128 shares of ABBV stock, worth $158 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
901,128
Previous 955,408 5.68%
Holding current value
$158 Million
Previous $164 Million 8.59%
% of portfolio
0.68%
Previous 0.64%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 06, 2024

SELL
$163.84 - $199.33 $8.89 Million - $10.8 Million
-54,280 Reduced 5.68%
901,128 $178 Million
Q2 2024

Jul 24, 2024

SELL
$154.79 - $180.76 $5.26 Million - $6.14 Million
-33,980 Reduced 3.43%
955,408 $164 Million
Q1 2024

Apr 30, 2024

BUY
$159.82 - $182.1 $90,937 - $103,614
569 Added 0.06%
989,388 $180 Million
Q4 2023

Feb 05, 2024

BUY
$137.6 - $154.97 $5.54 Million - $6.24 Million
40,235 Added 4.24%
988,819 $153 Million
Q3 2023

Nov 06, 2023

SELL
$133.59 - $154.65 $252,084 - $291,824
-1,887 Reduced 0.2%
948,584 $141 Million
Q2 2023

Jul 31, 2023

SELL
$132.51 - $164.9 $16.1 Million - $20.1 Million
-121,734 Reduced 11.35%
950,471 $128 Million
Q1 2023

May 01, 2023

SELL
$144.61 - $166.54 $6.34 Million - $7.3 Million
-43,837 Reduced 3.93%
1,072,205 $171 Million
Q4 2022

Feb 06, 2023

SELL
$138.31 - $165.87 $2.87 Million - $3.44 Million
-20,720 Reduced 1.82%
1,116,042 $180 Million
Q3 2022

Nov 04, 2022

BUY
$134.21 - $153.93 $195,275 - $223,968
1,455 Added 0.13%
1,136,762 $153 Million
Q2 2022

Aug 03, 2022

BUY
$137.62 - $174.96 $9,082 - $11,547
66 Added 0.01%
1,135,307 $174 Million
Q1 2022

Apr 20, 2022

SELL
$131.98 - $163.75 $4.17 Million - $5.18 Million
-31,633 Reduced 2.71%
1,135,241 $184 Million
Q4 2021

Jan 20, 2022

SELL
$107.43 - $135.93 $2.26 Million - $2.87 Million
-21,080 Reduced 1.77%
1,166,874 $158 Million
Q3 2021

Nov 03, 2021

SELL
$106.4 - $120.78 $4.17 Million - $4.74 Million
-39,223 Reduced 3.2%
1,187,954 $128 Million
Q2 2021

Jul 21, 2021

SELL
$105.21 - $117.21 $4.59 Million - $5.12 Million
-43,666 Reduced 3.44%
1,227,177 $138 Million
Q1 2021

Apr 15, 2021

SELL
$102.3 - $112.62 $24.1 Million - $26.5 Million
-235,493 Reduced 15.63%
1,270,843 $138 Million
Q4 2020

Jan 26, 2021

SELL
$80.49 - $108.67 $182,390 - $246,246
-2,266 Reduced 0.15%
1,506,336 $161 Million
Q3 2020

Oct 20, 2020

SELL
$85.91 - $100.83 $8.74 Million - $10.3 Million
-101,751 Reduced 6.32%
1,508,602 $132 Million
Q2 2020

Jul 23, 2020

BUY
$73.37 - $98.18 $22.3 Million - $29.9 Million
304,571 Added 23.32%
1,610,353 $158 Million
Q1 2020

Apr 20, 2020

SELL
$64.5 - $97.79 $4.6 Million - $6.97 Million
-71,305 Reduced 5.18%
1,305,782 $99.5 Million
Q4 2019

Jan 28, 2020

SELL
$72.13 - $90.25 $1.22 Million - $1.53 Million
-16,972 Reduced 1.22%
1,377,087 $122 Million
Q3 2019

Oct 30, 2019

BUY
$62.98 - $75.72 $4.73 Million - $5.68 Million
75,025 Added 5.69%
1,394,059 $106 Million
Q2 2019

Jul 09, 2019

BUY
$65.7 - $83.98 $9.95 Million - $12.7 Million
151,470 Added 12.97%
1,319,034 $95.9 Million
Q1 2019

Apr 15, 2019

SELL
$77.14 - $90.79 $883,715 - $1.04 Million
-11,456 Reduced 0.97%
1,167,564 $94.1 Million
Q4 2018

Jan 10, 2019

BUY
$77.85 - $96.01 $16.8 Million - $20.7 Million
215,400 Added 22.35%
1,179,020 $109 Million
Q3 2018

Oct 24, 2018

BUY
$88.91 - $98.84 $17.6 Million - $19.5 Million
197,400 Added 25.76%
963,620 $91.1 Million
Q2 2018

Jul 17, 2018

SELL
$89.78 - $106.23 $41.9 Million - $49.6 Million
-466,606 Reduced 37.85%
766,220 $71 Million
Q1 2018

Apr 27, 2018

SELL
$92.01 - $123.21 $1.01 Million - $1.35 Million
-10,993 Reduced 0.88%
1,232,826 $117 Million
Q4 2017

Feb 08, 2018

SELL
$89.56 - $98.21 $77,200 - $84,657
-862 Reduced 0.07%
1,243,819 $120 Million
Q3 2017

Nov 06, 2017

BUY
$69.85 - $89.22 $86.9 Million - $111 Million
1,244,681
1,244,681 $111 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $311B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Retirement Systems Of Alabama Portfolio

Follow Retirement Systems Of Alabama and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Systems Of Alabama, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Systems Of Alabama with notifications on news.